Chemomab Therapeutics (CMMB) Other Non-Current Assets (2017 - 2026)
Chemomab Therapeutics' Other Non-Current Assets came in at $123,000 for Q2 2026, down 58.7% from $298,000 a year earlier and down 26.3% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Other Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Other Non-Current Assets was $211,000, down 45.2% from FY2024.
- Other Non-Current Assets has declined in each of the last four years, though with a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $385,000 in FY2024 (-31.1%), $559,000 in FY2023 (-23.7%), $733,000 in FY2022 (-19.3%) and $908,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Assets since Q1 2021.
- Year-over-year, Other Non-Current Assets has declined for 17 consecutive quarters, with an average decline of 40.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Other Non-Current Assets ranged from 17.5% (Q2 2022) to 58.7% (Q2 2026).
- Business Quant data shows CMMB's Other Non-Current Assets at $167,000 (Q1 2026), $211,000 (Q4 2025) and $254,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Chemomab Therapeutics | 8.56 Mn | 8.56 Mn | - | 123,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123,000.00 |
| Mar 31, 2026 | 167,000.00 |
| Dec 31, 2025 | 211,000.00 |
| Sep 30, 2025 | 254,000.00 |
| Jun 30, 2025 | 298,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Dec 31, 2024 | 385,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 516,000.00 |
| Dec 31, 2023 | 559,000.00 |
| Sep 30, 2023 | 603,000.00 |
| Jun 30, 2023 | 646,000.00 |
| Mar 31, 2023 | 690,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Sep 30, 2022 | 776,000.00 |
| Jun 30, 2022 | 821,000.00 |
| Mar 31, 2022 | 864,000.00 |
| Dec 31, 2021 | 908,000.00 |
| Sep 30, 2021 | 952,000.00 |
API Access
Chemomab Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();